Search Results 421-430 of 4527 for 搜索引擎查看咨询邮箱：lgooxc@hotmail.com

  1. Paschalis Vergidis, M.D., M.S. - Mayo Clinic Faculty Profiles

    Paschalis Vergidis, M.D., investigates the epidemiology, diagnosis and treatment of fungal infections such as candidiasis, aspergillosis and endemic mycoses ...

  2. Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma - Mayo Clinic

    About this study. The purpose of this study is to determine how polyamine depletion impacts extracellular intratumoral guanidinoacetate abundance.

  3. Faculty and staff - Mayo Clinic Research

    See faculty and staff in the Aging and Dementia Imaging Research Lab at Mayo Clinic.

  4. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

    About this study. This is a Phase 1b, open label, multi-center study of CMB305 (sequentially administered LV305 [a dendritic cell-targeting viral vector ...

  5. A Study to Create a Registry for Patients at High-Risk for Pancreatic Cancer - Mayo Clinic

    This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC). and to ...

  6. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

    The purpose of this study is to compare, in a non-inferiority fashion, the progression-free survival (PFS) in patients with metastatic refractory gastric/ ...

  7. Faculty and staff - Mayo Clinic Research

    See faculty and staff in the Aging and Dementia Imaging Research Lab at Mayo Clinic.

  8. Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast ...

  10. Urology Physician Update e-Edition

    Bimonthly eNewsletter focused on trends and advances in urology and urologic surgery.